Gaining Insights Into Disease Biology for Target Identification and Validation

6 August 2020 , Brought to you by Agilent
Posted in Archive | Tagged , , , , ,

Gaining Insights Into Disease Biology for Target Identification and Validation

Sponsored by Agilent

Dysfunctional energy metabolism is associated with many different diseases. As such, metabolic modulation is a promising avenue for novel targets in cancer, immunology, and neurological disease.

Learn how live-cell metabolic measurements generate critical information about pathways and nutrients used to produce ATP and provide insights into cellular function.

—

If you want to download the full white paper you can get access here.

Related Articles

No related posts.

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free